Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Dag Hofsø"'
Autor:
Annika Wahlström, Ömrüm Aydin, Lisa M. Olsson, Wilhelm Sjöland, Marcus Henricsson, Annika Lundqvist, Hanns-Ulrich Marschall, Rutger Franken, Arnold van de Laar, Victor Gerdes, Abraham S. Meijnikman, Dag Hofsø, Albert K. Groen, Jøran Hjelmesæth, Max Nieuwdorp, Fredrik Bäckhed
Publikováno v:
EBioMedicine, Vol 106, Iss , Pp 105265- (2024)
Summary: Background: Bariatric surgery is an effective treatment option for obesity and provides long-term weight loss and positive effects on metabolism, but the underlying mechanisms are poorly understood. Alterations in bile acid metabolism have b
Externí odkaz:
https://doaj.org/article/64840ca30a314f63b2613355386bee20
Autor:
Kathrine Aglen Seeberg, Dag Hofsø, Heidi Borgeraas, John Olav Grimnes, Farhat Fatima, Lars Thomas Seeberg, Nils Petter Kvan, Marius Svanevik, Jens Kristoffer Hertel, Jøran Hjelmesæth
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Obesity, non-alcoholic fatty liver disease (NAFLD) and insulin resistance are three pathological conditions highly correlated, but this relationship is not fully elucidated. Hence, we aimed to assess the association of hepatic ste
Externí odkaz:
https://doaj.org/article/dde293a7fdfa475f8687b21aaf297a5e
Autor:
Dag Hofsø, Randi Størdal Lund, Kenneth Knutsen, Stig Arne Kjellevold, Line Kristin Johnson, Jøran Hjelmesæth
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Rune Sandbu, Nils Petter Kvan, Dag Hofsø, John Olav Grimnes, Jens Kristoffer Hertel, Heidi Borgeraas, Morten Lindberg, Lars Thomas Seeberg, Farhat Fatima, Jøran Hjelmesæth, Milada Cvancarova Småstuen, Kathrine Aglen Seeberg
Publikováno v:
Annals of Internal Medicine. 175:74-83
Background Weight loss improves fatty liver disease. No randomized trial has compared the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) on liver fat content and fibrosis. Objective To compare the 1-year effects of SG and RYGB
Autor:
Jolanta Lorentzen, Asle W. Medhus, Dag Hofsø, Marius Svanevik, Birgitte Seip, Jøran Hjelmesæth
Publikováno v:
International Journal of Obesity. 46:1936-1937
Publikováno v:
Journal of Gastrointestinal Surgery. 26:2031-2032
Publikováno v:
Obes Rev
Bariatric surgery is an effective treatment option for patients with type 2 diabetes mellitus (T2DM) and obesity. This study aims to compare the effects of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on remission of T2DM. MEDLINE, EMB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8128d3ba5e9d689b37187bc953b2604
https://europepmc.org/articles/PMC9113703/
https://europepmc.org/articles/PMC9113703/
Autor:
Tor-Ivar Karlsen, Dag Hofsø, Rune Sandbu, Asle W. Medhus, Marius Svanevik, Jøran Hjelmesæth, Ronette L. Kolotkin, Jolanta Lorentzen, Birgitte Seip, Heidi Borgeraas, Daniel Sifrim, Jens Kristoffer Hertel
Publikováno v:
Obesity Surgery. 30:2667-2675
Type 2 diabetes (T2DM) is associated with gastroesophageal reflux disease (GERD) in the general population, but the relationship between these conditions in candidates for bariatric surgery is uncertain. We compared the prevalence of GERD and the ass
Autor:
Lisa H. Barstad, Line K. Johnson, Heidi Borgeraas, Dag Hofsø, Marius Svanevik, Milada C. Småstuen, Jens K. Hertel, Jøran Hjelmesæth
Background The randomized Oseberg study compared the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), on the 1-year remission of type 2 diabetes and beta-cell function (primary outcomes). However, little is known about the comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c210602ae8269a2036c96c2a4a854a3
http://hdl.handle.net/10852/99307
http://hdl.handle.net/10852/99307
Autor:
Farhat Fatima, Jøran Hjelmesæth, Jens Kristoffer Hertel, Marius Svanevik, Rune Sandbu, Milada Cvancarova Småstuen, Dag Hofsø
Publikováno v:
Obesity surgery. 32(3)
Prediction of type 2 diabetes (T2DM) remission is an important part of risk-benefit assessment before bariatric surgery.Advanced-DiaRem (Ad-DiaRem) and ABCD diabetes remission scores for sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) wer